Nuclear Cardiology continues to be a powerful tool for assessing myocardial perfusion, viability, and function. During WCC 2026, this session will showcase innovations in SPECT, PET, and hybrid imaging modalities (e.g., PET/CT, PET/MR). Topics will include radiopharmaceuticals, quantitative perfusion analysis, AI-driven image interpretation, and cost-effectiveness in different healthcare settings. Real-world data on risk stratification in coronary artery disease and heart failure will be highlighted, alongside evolving guidelines and best practices.